Item Type No Grouping

Article

Antimicrobial resistance and reduced susceptibility in Clostridium difficile: potential consequences for induction, treatment, and recurrence of C. difficile infection. (2015) Simon D. Baines and M. H. Wilcox

In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile. (2015) D. Corbett, A. Wise, S. Birchall, P. Warn, Simon D. Baines, G. Crowther, J. Freeman, C. H. Chilton, J. Vernon, M. H. Wilcox and R. J. Vickers picture_as_pdf

SMT19969 as a treatment for Clostridium difficile infection : an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model. (2015) Simon D. Baines, G. S. Crowther, J. Freeman, S. Todhunter, R. Vickers and M. H. Wilcox

In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection. (2013) C. H. Chilton, G. S. Crowther, Simon D. Baines, S. L. Todhunter, J. Freeman, H. H. Locher, A. Athanasiou and M. H. Wilcox picture_as_pdf

Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery. (2013) C. H. Chilton, J. Freeman, Simon D. Baines, G. S. Crowther, S. Nicholson and M. H. Wilcox picture_as_pdf

Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model. (2011) Simon D. Baines, Alan R. Noel, Grace S. Huscroft, Sharie L. Todhunter, Rachael O'Connor, Joanne K. Hobbs, Jane Freeman, Andy M. Lovering and M. H. Wilcox picture_as_pdf

Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole. (2011) Jane Freeman, Simon D. Baines, Sharie L. Todhunter, Grace S. Huscroft and M. H. Wilcox picture_as_pdf

The changing epidemiology of Clostridium difficile infections. (2010) J. Freeman, M. P. Bauer, Simon D. Baines, J. Corver, W. N. Fawley, B. Goorhuis, E. J. Kuijper and M. H. Wilcox picture_as_pdf

Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model. (2009) Simon D. Baines, Rachel O'Connor, Katie Saxton, Jane Freeman and M. H. Wilcox picture_as_pdf

Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. (2009) Sarah Underwood, Shuang Guan, Vinod Vijayasubhash, Simon D. Baines, Luke Graham, Richard J. Lewis, M. H. Wilcox and Keith Stephenson picture_as_pdf

Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model. (2009) Katie Saxton, Simon D. Baines, Jane Freeman, Rachael O'Connor and M. H. Wilcox picture_as_pdf

Tolevamer is not efficacious in the neutralization of cytotoxin in a human gut model of Clostridium difficile infection. (2009) Simon D. Baines, Jane Freeman and M. H. Wilcox picture_as_pdf

Emergence of reduced susceptibility to metronidazole in Clostridium difficile. (2008) Simon D. Baines, Rachael O'Connor, Jane Freeman, Warren N Fawley, Celine Harmanus, Paola Mastrantonio, Ed J. Kuijper and M. H. Wilcox picture_as_pdf

Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. (2007) Warren N Fawley, Sarah Underwood, Jane Freeman, Simon D. Baines, Katie Saxton, Keith Stephenson, Robert C. Owens and M. H. Wilcox

Conference or Workshop Item

In vitro assessment of Clostridium difficile PCR ribotype 002: the most prevalent C. difficile ribotype in the United Kingdom. (2015) Simon Baines, Iye Ameh, Jane Freeman, W N Fawley and M. H. Wilcox

Other

Short-term genomic stability of Clostridium difficile within patients and a gut model. (2011) D. W. Eyre, C. Ip, R. M. Harding, J. Freeman, Simon D. Baines, W. N. Fawley, S.D. Walker, D. W. Crook, T. E. A. Peto and M. H. Wilcox

Efficacy of novel antimicrobial agent SMT-19969 (SMT) against simulated Clostridium difficile infection in an in vitro human gut model. (2011) Simon D. Baines, J. Freeman, Grace S. Huscroft, Sharie L. Todhunter, M. H. Wilcox and R. Vickers

SMT19969 – a novel antibiotic for C. difficile : Clostridium difficile growth inhibition, spectrum of activity and resistance development. (2011) R. Vickers, J. Tinsley, R. Storer, F. Wilson, C. Dorgan, S. Wren, M. H. Wilcox, Simon D. Baines and J. Freeman